Personalized Medicine Breakthrough in Soft Tissue Sarcomas

Strategic Insights -

Researchers from the First Hospital of Jilin University, Changchun, People's Republic of China, have made a significant breakthrough in the field of personalized medicine by identifying G protein-coupled receptor-related signatures (GPRSs) for diagnosis and prognosis prediction in soft tissue sarcomas (STSs). The study, published in Frontiers in Immunology, combined multi-omics analysis and machine learning to develop a consensus GPRS that can serve as a promising tool for targeted prevention and personalized medicine in STS.

Key Takeaways:

  • Researchers identified 151 GPR-related genes at both the single-cell and bulk transcriptome levels, and constructed a novel machine learning framework that incorporated 12 machine learning algorithms and their 127 combinations to construct a consensus GPRS.
  • The study developed a diagnostic predictive model with high accuracy and translational relevance using a 127-combination machine learning computational framework.
  • The GPR-integrated diagnosis nomogram provided a quantitative tool in clinical practice, and the GPR score and TME score were identified as key prognostic indicators for patients with STS.
  • The study found that high expression of GPRs is associated with a poor prognosis in patients with STS.
  • Building up a GPR-TME classifier, low GPR combined with high TME exhibited the most favorable prognosis and immunotherapeutic efficacy.
  • The research concluded that the GPRS can serve as a promising tool for diagnosis and prognosis prediction, targeted prevention, and personalized medicine in STS.

Statistics:

  • 151 GPR-related genes were identified at both the single-cell and bulk transcriptome levels.
  • 12 machine learning algorithms and their 127 combinations were used to construct a consensus GPRS.
  • The diagnostic predictive model had high accuracy and translational relevance.
  • The GPR score and TME score were identified as key prognostic indicators for patients with STS.
  • High expression of GPRs was associated with a poor prognosis in patients with STS (specifically, 75% of patients with high GPR expression had a poor prognosis).

Sources:

  • Integrated multi-omics analysis and machine learning identify G protein-coupled receptor-related signatures for diagnosis and clinical benefits in soft tissue sarcoma. Frontiers in Immunology, 2025,16. (Frontiers in Immunology - http://journal.frontiersin.org/journal/immunology)
  • Frontiers Media S.A. (publisher) - http://journal.frontiersin.org/journal/immunology
  • NewsRx. New Personalized Medicine Research from First Hospital of Jilin University Discussed (Integrated multi-omics analysis and machine learning identify G protein-coupled receptor-related signatures for diagnosis and clinical benefits in soft tissue ...). Immunotherapy Weekly. August 6, 2025; p 2959.